Skip to main content

Release not found

This press release isn’t in the live store anymore. Open the original on the wire, or jump into the live feed.

Go to feed
U.S. FDA Approves Pfizer’s HYMPAVZI for the Treatment of Two Additional Hemophilia A or B Patient Populations with Significant Medical Need · Pfizer — Press Releases · PPN World